Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety

Vaccine maker Novavax is starting a large coronavirus vaccine trial in the U.K. Gregory Glenn, the company's president of research and development, talks with NPR about how vaccines are tested.

(Image credit: Andrew Caballero-Reynolds/AFP via Getty Images)